Metabolic syndrome in Bantu subjects with type 2 diabetes from sub-Saharan extraction. Prevalence, gender differences and HOMA hyperbolic product

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 2, Issue 1, 2008, Pages 5-11

  Dehout, Florence ^a   Haumont, Sophie ^a   Gaham, Nezli ^a   Amoussou Guenou, K Daniel ^b   Hermans, Michel P ^c  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b CNHU HKM   (Benin)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Africa; Diabetes; Ethnicity; Insulin resistance; Metabolic syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; TRIACYLGLYCEROL;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; BELGIUM; CAUCASIAN; CELL FUNCTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA EXTRACTION; DEMOGRAPHY; DEVELOPING COUNTRY; DOCUMENTATION; FEMALE; FOOD; HUMAN; IMMIGRANT; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET BETA CELL; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; URBANIZATION; VASCULAR DISEASE; WAIST CIRCUMFERENCE;

EID: 38949214069     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2007.11.008     Document Type: Article

References (32)

1. Sadikot S.M., and Misra A. The metabolic syndrome: an exercise in utility or futility?. Diabetes Metab Synd Clin Res Rev 1 (2007) 3-21
2. Banerji M.A., and Lebovitz H.E. Remission in non-insulin-dependent diabetes mellitus: clinical characteristics of remission and relapse in black patients. Medicine 69 (1990) 176-185
3. Banerji M.A., Chaiken R.L., and Lebovitz H.E. Long-term normoglycemic remission in black newly diagnosed NIDDM subjects. Diabetes 45 (1996) 337-341
4. Sobngwi E., Mauvais-Jarbis F., Vexiau P., Mbanya J.C., and Gautier JF. Diabetes in Africans. Diabetes Metab 27 (2001) 628-634 [2002;28:5-12]
5. Hermans M.P., Dumont C., and Buysschaert M. Clinical, biophysical and biochemical variables from African-heritage subjects with type 2 diabetes. Acta Clin Belg 57 (2002) 134-141
6. Osei K., Schuster D.P., Amoah A.G.B., and Owusu S.K. Pathogenesis of type 1 and type 2 diabetes mellitus in sub-Saharan Africa: implication for transitional populations. J Cardiovasc Risk 10 (2003) 85-96
7. Nesbitt S.D., and Victor R.G. Pathogenesis of hypertension in African Americans. Congest Heart Fail 10 (2004) 24-29
8. Nesbitt S.D. Hypertension in black patients: special issues and considerations. Curr Cardiol Rep 6 (2004) 416-420
9. Sumner A.E., Vega G.L., Genovese D.J., Finley K.B., Bergman R.N., and Boston R.C. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism 54 (2005) 902-909
10. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002;106:3143-421.
11. Grundy S.M., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
12. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
13. Levy J.C., Matthews D.R., and Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998) 2191-2192
14. Hermans M.P., Levy J., Morris R.J., and Turner R.C. Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48 (1999) 1779-1786
15. Hermans M.P., Levy J., Morris R.J., and Turner R.C. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42 (1999) 678-687
16. Hermans M.P. Comment mesurer et interpréter en pratique la mesure combinée de la sensibilité à l'insuline et de la fonction sécrétoire beta. Louvain Med 125 (2006) S82-S89
17. Hermans M.P. Diabetic macro- and microvascular disease in type 2 diabetes. Diabetes Vasc Dis Res 4 (2007) S7-S11
18. Preumont V., Hermans M., Lebecque P., and Buysschaert M. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with gene CFTR ΔF 508 mutation. Diabetes Care 30 (2007) 1187-1192
19. Kahn S.E., Prigeon R.L., Mc Culloch D.K., Boyko E.J., Berman R.N., Schwartz M.W., et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42 (1993) 1663-1672
20. Bergman R.N., Watanabe R., Rebrin K., Ader M., and Steil G. Toward an integrated phenotype in pre-NIDDM. Diabet Med 13 Suppl. 6 (1996) S67-S77
21. Bergman R.N. Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology. Mt Sinai J Med 69 (2002) 280-290
22. Guerrero-Romero F., and Rodriguez-Moran. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus. Eur J Clin Invest 36 (2006) 796-802
23. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
24. Selvais P.L., and Hermans M.P. Characterization of type 2 diabetes mellitus in first generation Italian migrants to Belgium. Acta Clin Belg 60 (2005) 362-368
25. Kumar S. In: O'Rahilly S. (Ed). Insulin resistance: insulin action and its disturbances in disease (2005), John Wiley & Sons Ltd., Chichester, UK
26. Hermans M.P., Manwa B., Fillée C., Kashongwe J.P., and Kolanowski J. Obesity and metabolic syndrome scoring in South Kivu subjects with diabetes mellitus: relation to HOMA insulin sensitivity and hyperbolic product beta-cell function. Int J Obes Suppl (2007)
27. UK Prospective Diabetes Study Group. XII: Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. UK Prospective Diabetes Study Group. Diabet Med 11 (1994) 670-677
28. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
29. Levy J., Atkinson A.B., Bell P.M., McCance D.R., and Hadden D.R. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med 15 (1998) 290-296
30. Turner R.C., Cull C.A., Frighi V., and Holman R.R. Glycemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (IKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281 (1999) 2005-2012
31. Thissen J.P., and Hermans MP. Aliments fonctionnels et diabète. In: Roberfroid (Ed). Les Aliments Fonctionnels, Sciences & Techniques Agro-alimentaires (2002), Editions TEC et DOC, Paris 245-278
32. Winter W.E., Mclaren N.K., Riley W.J., Clarke D.W., Kappy M.S., and Spillar I.P. Maturity-onset diabetes of youth in black Americans. N Engl J Med 316 (1987) 285-291